European Commission Approves PBT2 Orphan Designation for Huntington’s Disease June 1, 2015August 16, 2022
PBT434 drug candidate shows potential as “next-generation” disease-modifying treatment in Parkinson’s Disease July 17, 2013August 16, 2022